March 24, 2020 / 8:18 PM / 4 days ago

BRIEF-Diffusion Pharmaceuticals - Expect Delays In Enrollment In Ambulance-Based Phast-Tsc Phase 2 Clinical Trial In Acute Stroke Due To Coronavirus

Diffusion Pharmaceuticals Inc:

* DIFFUSION PHARMACEUTICALS ANTICIPATES ENROLLMENT IN ITS AMBULANCE-BASED STROKE TRIAL WILL BE SLOWED DUE TO THE IMPACT OF THE CORONAVIRUS

* DIFFUSION PHARMACEUTICALS - EXPECT DELAYS IN ENROLLMENT IN AMBULANCE-BASED PHAST-TSC PHASE 2 CLINICAL TRIAL IN ACUTE STROKE DUE TO CORONAVIRUS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below